Pivotal bioVenture Partners China
Overview
Pivotal bioVenture Partners China, a member of Nan Fung Life Sciences, is a venture capital firm specializing in venture building in the life sciences industry. Its investment strategy is centered on identifying promising innovative products and technologies and bringing them to serve the growing unmet medical needs in Greater China region by building new ventures. Its investment areas include therapeutics, medical devices and medical services. The Pivotal China team includes experienced life science investors and entrepreneurs with successful track records of venture building and investing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ablaze Pharmaceuticals | Nov 2021 | Series A | Co-investor |
| OncXerna Therapeutics, Inc. | Jan 2021 | Series B | Co-investor |
| HerAnova Lifesciences | Dec 2023 | Seed | Co-investor |
| Feng Biosciences | Jun 2019 | Series B | Lead |
| Plexium | Feb 2022 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Pivotal bioVenture Partners China based?
Pivotal bioVenture Partners China is headquartered in Shanghai, Shanghai, China.
When was Pivotal bioVenture Partners China founded?
Pivotal bioVenture Partners China was founded in 2017.
How many portfolio companies does Pivotal bioVenture Partners China have?
Pivotal bioVenture Partners China has 7 portfolio companies in Caplight's dataset.
What are some companies in Pivotal bioVenture Partners China's portfolio?
Portfolio companies visible on Caplight include Ablaze Pharmaceuticals, OncXerna Therapeutics, Inc., HerAnova Lifesciences, Feng Biosciences, Plexium.
What was Pivotal bioVenture Partners China's most recent investment shown here?
Pivotal bioVenture Partners China's most recent investment in this portfolio sample was in HerAnova Lifesciences in 2023.
What sectors does Pivotal bioVenture Partners China focus on?
Pivotal bioVenture Partners China focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Pivotal bioVenture Partners China focus on?
Pivotal bioVenture Partners China typically invests at the Early stage.
What is Pivotal bioVenture Partners China's AUM?
Pivotal bioVenture Partners China's assets under management are estimated between $500.0M and $1.0B.